How are IVZ strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the IVZ strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 36.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$242.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a IVZ strangle?

The breakeven for the IVZ strangle priced on this page is roughly $23.58 and $30.43 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IVZ market-implied 1-standard-deviation expected move is approximately 10.35%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current IVZ implied volatility affect this strangle?

IVZ ATM IV is at 36.10% with IV rank near 44.67%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

IVZ Strangle Strategy

IVZ (Invesco Ltd.), in the Financial Services sector, (Asset Management industry), listed on NYSE.

Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds. It manages separate client-focused equity and fixed income portfolios. The firm also launches equity, fixed income, commodity, multi-asset, and balanced mutual funds for its clients. It launches equity, fixed income, multi-asset, and balanced exchange-traded funds. The firm also launches and manages private funds.

IVZ (Invesco Ltd.) trades in the Financial Services sector, specifically Asset Management, with a market capitalization of approximately $12.45B, a beta of 1.57 versus the broader market, a 52-week range of 14.1-29.61, average daily share volume of 5.5M, a public-listing history dating back to 1995, approximately 8K full-time employees. These structural characteristics shape how IVZ stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.57 indicates IVZ has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. IVZ pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a strangle on IVZ?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current IVZ snapshot

As of May 15, 2026, spot at $27.12, ATM IV 36.10%, IV rank 44.67%, expected move 10.35%. The strangle on IVZ below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this strangle structure on IVZ specifically: IVZ IV at 36.10% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 10.35% (roughly $2.81 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IVZ expiries trade a higher absolute premium for lower per-day decay. Position sizing on IVZ should anchor to the underlying notional of $27.12 per share and to the trader's directional view on IVZ stock.

IVZ strangle setup

The IVZ strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IVZ near $27.12, the first option leg uses a $28.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IVZ chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IVZ shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$28.00	$1.33
Buy 1	Put	$26.00	$1.10

IVZ strangle risk and reward

Net Premium / Debit: -$242.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$242.50
Breakeven(s): $23.58, $30.43
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

IVZ strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on IVZ. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$2,356.50
$6.01	-77.9%	+$1,756.97
$12.00	-55.8%	+$1,157.44
$18.00	-33.6%	+$557.92
$23.99	-11.5%	-$41.61
$29.99	+10.6%	-$43.86
$35.98	+32.7%	+$555.67
$41.98	+54.8%	+$1,155.19
$47.97	+76.9%	+$1,754.72
$53.97	+99.0%	+$2,354.25

When traders use strangle on IVZ

Strangles on IVZ are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the IVZ chain.

IVZ thesis for this strangle

The market-implied 1-standard-deviation range for IVZ extends from approximately $24.31 on the downside to $29.93 on the upside. A IVZ long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current IVZ IV rank near 44.67% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on IVZ should anchor more to the directional view and the expected-move geometry. As a Financial Services name, IVZ options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IVZ-specific events.

IVZ strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IVZ positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IVZ alongside the broader basket even when IVZ-specific fundamentals are unchanged. Always rebuild the position from current IVZ chain quotes before placing a trade.

Frequently asked questions

What is a strangle on IVZ?: A strangle on IVZ is the strangle strategy applied to IVZ (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With IVZ stock trading near $27.12, the strikes shown on this page are snapped to the nearest listed IVZ chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are IVZ strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the IVZ strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 36.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$242.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a IVZ strangle?: The breakeven for the IVZ strangle priced on this page is roughly $23.58 and $30.43 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IVZ market-implied 1-standard-deviation expected move is approximately 10.35%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on IVZ?: Strangles on IVZ are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the IVZ chain.
How does current IVZ implied volatility affect this strangle?: IVZ ATM IV is at 36.10% with IV rank near 44.67%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.